ERCC1 expression can predict survival in patients with advanced head and neck cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷 / 10期
关键词：
D O I：
10.1038/ncponc0915
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：559 / 559
相关论文
共 50 条
  • [31] Clinical significance of ERCC1 expression in advanced squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
    Jun, H.
    Ahn, M.
    Kim, H.
    Park, B.
    Han, J.
    Ahn, Y.
    Jeong, H.
    Son, Y.
    Baek, J.
    Park, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Can machine-learning model predict overall survival in head and neck cancer patients?
    Gonzalez Ruiz, Maria Angeles
    Wals Zurita, Amadeo
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S138 - S139
  • [33] ERCC1 expression in triple negative breast cancer
    Ozkan, C.
    Gumuskaya, B.
    Yaman, S.
    Aksoy, S.
    Guler, G.
    Altundag, K.
    [J]. JOURNAL OF BUON, 2012, 17 (02): : 271 - 276
  • [34] Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment
    Duran, Goretti
    Aguin, Santiago
    Cruz, Raquel
    Barros, Francisco
    Maria Giraldez, Jose
    Bernardez, Beatriz
    Lopez-Lopez, Rafael
    Carracedo, Angel
    Jesus Lamas, Maria
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (08): : 2704 - 2715
  • [35] Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC)
    Guancial, Elizabeth A.
    Werner, Lillian
    Bellmunt, Joaquim
    Nikitas, Nikitas
    Stack, Edward C.
    Lis, Rosina
    Signoretti, Sabina
    Loda, Massimo
    Regan, Meredith M.
    Park, Rachel S.
    O'Brien, Robert
    Berman, David M.
    Bamias, Aristotelis
    Rosenberg, Jonathan E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [36] ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis
    Li, Shan
    Wu, Junrong
    Chen, Yongbin
    Tang, Weizhong
    Peng, Qiliu
    Deng, Yan
    Xie, Li
    Wang, Jian
    Huang, Shan
    Li, Ruolin
    Qin, Xue
    Zhao, Jinmin
    [J]. ANTI-CANCER DRUGS, 2014, 25 (01) : 106 - 114
  • [37] ERCC1 expression of small cell lung cancer
    Hennemann, Marluce
    Sostruznik, Maria H.
    Gaiger, Ana
    Barrios, Carlos H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S807 - S807
  • [38] ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy
    Sakano, Shigeru
    Ogawa, Satoshi
    Yamamoto, Yoshiaki
    Nishijima, Jun
    Miyachika, Yoshihiro
    Matsumoto, Hiroaki
    Hara, Takahiko
    Matsuyama, Hideyasu
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 403 - 410
  • [39] Clinicopathological significance of ERCC1 expression in breast cancer
    Gerhard, Rene
    Carvalho, Ana
    Carneiro, Vitor
    San Bento, Rui
    Uemura, Gilberto
    Gomes, Madalena
    Albergaria, Andre
    Schmitt, Fernando
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (06) : 331 - 336
  • [40] ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy
    Ge, Hong
    Lu, Yufei
    Chen, Yongshun
    Zheng, Xiaoli
    Wang, Wen
    Yu, Jinming
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (10) : 656 - 661
12345